Medicare & Medicaid restructuring analysis highlights lack of price transparency and rising high‑end procedures

Medicare & Medicaid restructuring analysis highlights lack of price transparency and rising high‑end procedures The passage provides generic policy commentary and statistical tables about healthcare costs, but it does not name any specific individuals, agencies, financial transactions, or wrongdoing. It offers limited investigative value beyond confirming known concerns about price opacity in US health care. Key insights: Patients face difficulty comparing prices due to complex market and insurance lock‑ins.; Physician guidance dominates consumer decision‑making, reducing price sensitivity.; High‑end surgeries have increased dramatically from 1970‑2004, funded largely by government subsidies.